News
Present results of the TACTIVE-N trial, a Phase 2 clinical trial of neoadjuvant vepdegestrant, in a mini oral session at European Society for Medical Oncology 2025 Congress (ClinicalTrials.gov ...
Trump administration terminates 22 mRNA vaccine contracts, shifting focus to safer alternatives, sparking controversy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback